Scarica l'app Stockscreener
0.41
0.19%
-0.0008
Precedente Chiudi:
$0.4108
Aprire:
$0.3977
Volume 24 ore:
298.55K
Relative Volume:
0.30
Capitalizzazione di mercato:
$1.67M
Reddito:
$1.93M
Utile/perdita netta:
$-3.10M
Rapporto P/E:
-0.0251
EPS:
-16.3657
Flusso di cassa netto:
$-1.93M
1 W Prestazione:
-5.09%
1M Prestazione:
-19.31%
6M Prestazione:
-63.06%
1 anno Prestazione:
-78.87%
Intervallo 1D:
$0.3967
$0.4482
Intervallo di 1 settimana:
$0.386
$0.474
Portata 52W:
$0.30
$3.37
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Confronta SXTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
0.41 | 1.67M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
170.90 | 77.10B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.47 | 42.82B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.39 | 42.45B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.73 | 20.09B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
151.82 | 15.37B | 2.24B | 385.90M | 440.10M | 3.73 |
China Sxt Pharmaceuticals Inc Borsa (SXTC) Ultime notizie
China SXT Pharmaceuticals, Inc. announced that it expects to receive $2.84 million in funding - Marketscreener.com
China SXT Pharmaceuticals Announces New Securities Purchase Agreement - MSN
China SXT Pharmaceuticals, Inc. Announces CEO Changes -January 23, 2025 at 04:15 pm EST - Marketscreener.com
Before Buying China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock, Read This First - Stocks Register
China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Up 1.5% – Should You Buy? - Defense World
SXTC stock hits 52-week low at $0.36 amid sharp annual decline - Investing.com
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Inkl
SXTC stock hits 52-week low at $0.37 amid sharp annual decline - Investing.com Australia
SXTC stock hits 52-week low at $0.43 amid sharp annual decline - Investing.com Australia
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com India
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
In the Green: China SXT Pharmaceuticals Inc (SXTC) Closes at 0.63, Up/Down 12.64 from Previous Day - The Dwinnex
SXTC’s Stock Market Adventure: -84.07% YTD Growth Amidst Volatility - The InvestChronicle
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
China SXT Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Insider’s View: Deciphering China SXT Pharmaceuticals Inc (SXTC)’s Financial Health Through Ratios - The Dwinnex
SXTC’s Market Whiplash: -83.70% YTD Decline, -22.51% Plunge in 30 Days - The InvestChronicle
How does SXTC’s price to cash per share ratio compare in the market? - US Post News
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decline in Short Interest - Defense World
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Quotes, Forecast and News Summary - Benzinga
China's First Generic Version of AstraZeneca's Xigduo XR Diabetes Pill Gets Green Light - Yicai Global
SIMPLY SOLVENTLESS PROVIDES Q3 2024 GUIDANCE INCLUDING RECORD PROJECTED QUARTERLY REVENUE AND EIGHTH STRAIGHT QUARTER OF NET INCOME PROFIT, AND ANNOUNCES UPCOMING PRODUCT LAUNCHES – Company A - Financial Times
China SXT Pharmaceuticals Inc (SXTC)’s results reveal risk - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock touches 52-week low at $0.6 amid sharp annual decline - Investing.com India
Closing Figures Unveiled: China SXT Pharmaceuticals Inc (SXTC) Drop -8.88, Closes at 0.63 - The Dwinnex
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com Australia
SXTC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Market Resilience: China SXT Pharmaceuticals Inc (SXTC) Finishes Weak at 0.94, Down -6.00 - The Dwinnex
China SXT Pharma stock hits 52-week low at $0.92 amid downturn - Investing.com India
SXTC stock hits 52-week low at $0.93 amid sharp annual decline - Investing.com India
Balance Sheet Insights: China SXT Pharmaceuticals Inc (SXTC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Market Watch Highlights: China SXT Pharmaceuticals Inc (SXTC) Ends on an Downturn Note at 1.06 - The Dwinnex
Successful Portfolios LLC Lowers Stock Holdings in The Southern Company (NYSE:SO) - Defense World
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
China SXT Pharmaceuticals: Operational Risks and Profit Repatriation Challenges - TipRanks
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule - Yahoo Finance
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - Yahoo Finance
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today? - InvestorPlace
China Sxt Pharmaceuticals Inc Azioni (SXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):